SEMA3C and hepatocellular carcinoma: To further validate the significance of AKT/Gli1 signaling in Sema3C-driven HCC stemness, functional rescue experiments were performed in which a specific AKT inhibitor MK2206 was introduced into the Sema3C overexpressing HCC cells.